Type |
Details |
Score |
Publication |
First Author: |
UniProt-GOA |
Year: |
2012 |
|
Title: |
Gene Ontology annotation based on UniProtKB/Swiss-Prot keyword mapping |
|
|
|
|
•
•
•
•
•
|
Publication |
First Author: |
The Gene Ontology Consortium |
Year: |
2010 |
|
Title: |
Automated transfer of experimentally-verified manual GO annotation data to mouse-human orthologs |
|
|
|
|
•
•
•
•
•
|
Publication |
First Author: |
Diez-Roux G |
Year: |
2011 |
Journal: |
PLoS Biol |
Title: |
A high-resolution anatomical atlas of the transcriptome in the mouse embryo. |
Volume: |
9 |
Issue: |
1 |
Pages: |
e1000582 |
|
•
•
•
•
•
|
Publication |
First Author: |
Mouse Genome Informatics |
Year: |
2010 |
Journal: |
Database Release |
Title: |
Protein Ontology Association Load. |
|
|
|
|
•
•
•
•
•
|
Publication |
First Author: |
Mouse Genome Informatics Scientific Curators |
Year: |
2009 |
Journal: |
Database Download |
Title: |
Mouse Microarray Data Integration in Mouse Genome Informatics, the Affymetrix GeneChip Mouse Genome 430 2.0 Array Platform |
|
|
|
|
•
•
•
•
•
|
Publication |
First Author: |
MGD Nomenclature Committee |
Year: |
1995 |
|
Title: |
Nomenclature Committee Use |
|
|
|
|
•
•
•
•
•
|
Publication |
First Author: |
Mouse Genome Informatics Scientific Curators |
Year: |
2010 |
Journal: |
Database Download |
Title: |
Mouse Microarray Data Integration in Mouse Genome Informatics, the Affymetrix GeneChip Mouse Genome U74 Array Platform (A, B, C v2). |
|
|
|
|
•
•
•
•
•
|
Publication |
First Author: |
Allen Institute for Brain Science |
Year: |
2004 |
Journal: |
Allen Institute |
Title: |
Allen Brain Atlas: mouse riboprobes |
|
|
|
|
•
•
•
•
•
|
Publication |
First Author: |
Bairoch A |
Year: |
1999 |
Journal: |
Database Release |
Title: |
SWISS-PROT Annotated protein sequence database |
|
|
|
|
•
•
•
•
•
|
Publication |
First Author: |
Mouse Genome Informatics Scientific Curators |
Year: |
2009 |
Journal: |
Database Download |
Title: |
Mouse Microarray Data Integration in Mouse Genome Informatics, the Affymetrix GeneChip Mouse Gene 1.0 ST Array Platform |
|
|
|
|
•
•
•
•
•
|
Publication |
First Author: |
Mouse Genome Informatics Group |
Year: |
2003 |
Journal: |
Database Procedure |
Title: |
Automatic Encodes (AutoE) Reference |
|
|
|
|
•
•
•
•
•
|
Publication |
First Author: |
Mouse Genome Database and National Center for Biotechnology Information |
Year: |
2000 |
Journal: |
Database Release |
Title: |
Entrez Gene Load |
|
|
|
|
•
•
•
•
•
|
Publication |
First Author: |
Mouse Genome Informatics Scientific Curators |
Year: |
2005 |
|
Title: |
Obtaining and Loading Genome Assembly Coordinates from Ensembl Annotations |
|
|
|
|
•
•
•
•
•
|
Publication |
First Author: |
Mouse Genome Informatics Scientific Curators |
Year: |
2005 |
|
Title: |
Obtaining and loading genome assembly coordinates from NCBI annotations |
|
|
|
|
•
•
•
•
•
|
Publication |
First Author: |
Liu Z |
Year: |
2011 |
Journal: |
Clin Exp Immunol |
Title: |
Chemokine CXCL11 links microbial stimuli to intestinal inflammation. |
Volume: |
164 |
Issue: |
3 |
Pages: |
396-406 |
|
•
•
•
•
•
|
Publication |
First Author: |
Callahan V |
Year: |
2021 |
Journal: |
Viruses |
Title: |
The Pro-Inflammatory Chemokines CXCL9, CXCL10 and CXCL11 Are Upregulated Following SARS-CoV-2 Infection in an AKT-Dependent Manner. |
Volume: |
13 |
Issue: |
6 |
|
|
•
•
•
•
•
|
Allele |
Name: |
chemokine (C-X-C motif) ligand 11; endonuclease-mediated mutation 1, Shanghai Model Organisms Center |
Allele Type: |
Endonuclease-mediated |
Attribute String: |
Null/knockout |
|
•
•
•
•
•
|
Strain |
Attribute String: |
coisogenic, mutant strain, endonuclease-mediated mutation |
|
•
•
•
•
•
|
Allele |
Name: |
transgene insertion HE40, GENSAT Project at Rockefeller University |
Allele Type: |
Transgenic |
Attribute String: |
Reporter |
|
•
•
•
•
•
|
Allele |
Name: |
transgene insertion KN257, GENSAT Project at Rockefeller University |
Allele Type: |
Transgenic |
Attribute String: |
Recombinase |
|
•
•
•
•
•
|
Strain |
Attribute String: |
mutant stock, transgenic |
|
•
•
•
•
•
|
Strain |
Attribute String: |
transgenic, mutant stock |
|
•
•
•
•
•
|
Publication |
First Author: |
Oh E |
Year: |
2018 |
Journal: |
Diabetes |
Title: |
Syntaxin 4 Expression in Pancreatic β-Cells Promotes Islet Function and Protects Functional β-Cell Mass. |
Volume: |
67 |
Issue: |
12 |
Pages: |
2626-2639 |
|
•
•
•
•
•
|
Publication |
First Author: |
Li XM |
Year: |
2015 |
Journal: |
J Inflamm (Lond) |
Title: |
Nur77 deficiency leads to systemic inflammation in elderly mice. |
Volume: |
12 |
|
Pages: |
40 |
|
•
•
•
•
•
|
Publication |
First Author: |
Zhang Y |
Year: |
2018 |
Journal: |
Am J Pathol |
Title: |
Reversing CXCL10 Deficiency Ameliorates Kidney Disease in Diabetic Mice. |
Volume: |
188 |
Issue: |
12 |
Pages: |
2763-2773 |
|
•
•
•
•
•
|
Publication |
First Author: |
Chen WY |
Year: |
2006 |
Journal: |
Arterioscler Thromb Vasc Biol |
Title: |
IL-20 is expressed in atherosclerosis plaques and promotes atherosclerosis in apolipoprotein E-deficient mice. |
Volume: |
26 |
Issue: |
9 |
Pages: |
2090-5 |
|
•
•
•
•
•
|
Publication |
First Author: |
Su SB |
Year: |
2007 |
Journal: |
Invest Ophthalmol Vis Sci |
Title: |
Altered chemokine profile associated with exacerbated autoimmune pathology under conditions of genetic interferon-gamma deficiency. |
Volume: |
48 |
Issue: |
10 |
Pages: |
4616-25 |
|
•
•
•
•
•
|
Publication |
First Author: |
Hannesdóttir L |
Year: |
2013 |
Journal: |
Eur J Immunol |
Title: |
Lapatinib and doxorubicin enhance the Stat1-dependent antitumor immune response. |
Volume: |
43 |
Issue: |
10 |
Pages: |
2718-29 |
|
•
•
•
•
•
|
Publication |
First Author: |
Su YC |
Year: |
2008 |
Journal: |
J Immunol |
Title: |
Granulocyte-macrophage colony-stimulating factor is required for bronchial eosinophilia in a murine model of allergic airway inflammation. |
Volume: |
180 |
Issue: |
4 |
Pages: |
2600-7 |
|
•
•
•
•
•
|
Publication |
First Author: |
Jin YZ |
Year: |
2008 |
Journal: |
Eur J Immunol |
Title: |
Reciprocal function of Galphai2 and Galphai3 in graft-versus-host disease. |
Volume: |
38 |
Issue: |
7 |
Pages: |
1988-98 |
|
•
•
•
•
•
|
Publication |
First Author: |
Saxena A |
Year: |
2014 |
Journal: |
Cardiovasc Res |
Title: |
CXCR3-independent actions of the CXC chemokine CXCL10 in the infarcted myocardium and in isolated cardiac fibroblasts are mediated through proteoglycans. |
Volume: |
103 |
Issue: |
2 |
Pages: |
217-27 |
|
•
•
•
•
•
|
Publication |
First Author: |
Kanai K |
Year: |
2018 |
Journal: |
J Immunol |
Title: |
Murine γ-Herpesvirus 68 Induces Severe Lung Inflammation in IL-27-Deficient Mice with Liver Dysfunction Preventable by Oral Neomycin. |
Volume: |
200 |
Issue: |
8 |
Pages: |
2703-2713 |
|
•
•
•
•
•
|
Publication |
First Author: |
Benson SA |
Year: |
2009 |
Journal: |
PLoS One |
Title: |
TLR2-dependent inhibition of macrophage responses to IFN-gamma is mediated by distinct, gene-specific mechanisms. |
Volume: |
4 |
Issue: |
7 |
Pages: |
e6329 |
|
•
•
•
•
•
|
Publication |
First Author: |
Monnier J |
Year: |
2012 |
Journal: |
Eur J Cancer |
Title: |
CXCR7 is up-regulated in human and murine hepatocellular carcinoma and is specifically expressed by endothelial cells. |
Volume: |
48 |
Issue: |
1 |
Pages: |
138-48 |
|
•
•
•
•
•
|
Publication |
First Author: |
Peng H |
Year: |
2016 |
Journal: |
Biochem Biophys Res Commun |
Title: |
Blocking CXCR7-mediated adipose tissue macrophages chemotaxis attenuates insulin resistance and inflammation in obesity. |
Volume: |
479 |
Issue: |
4 |
Pages: |
649-655 |
|
•
•
•
•
•
|
Publication |
First Author: |
Ameti R |
Year: |
2018 |
Journal: |
J Leukoc Biol |
Title: |
Characterization of a chimeric chemokine as a specific ligand for ACKR3. |
Volume: |
104 |
Issue: |
2 |
Pages: |
391-400 |
|
•
•
•
•
•
|
Publication |
First Author: |
Burke SJ |
Year: |
2016 |
Journal: |
Biofactors |
Title: |
Pancreatic β-Cell production of CXCR3 ligands precedes diabetes onset. |
Volume: |
42 |
Issue: |
6 |
Pages: |
703-715 |
|
•
•
•
•
•
|
Publication |
First Author: |
Burns JM |
Year: |
2006 |
Journal: |
J Exp Med |
Title: |
A novel chemokine receptor for SDF-1 and I-TAC involved in cell survival, cell adhesion, and tumor development. |
Volume: |
203 |
Issue: |
9 |
Pages: |
2201-13 |
|
•
•
•
•
•
|
Publication |
First Author: |
Gerrits H |
Year: |
2008 |
Journal: |
Genesis |
Title: |
Early postnatal lethality and cardiovascular defects in CXCR7-deficient mice. |
Volume: |
46 |
Issue: |
5 |
Pages: |
235-45 |
|
•
•
•
•
•
|
Publication |
First Author: |
Naumann U |
Year: |
2010 |
Journal: |
PLoS One |
Title: |
CXCR7 functions as a scavenger for CXCL12 and CXCL11. |
Volume: |
5 |
Issue: |
2 |
Pages: |
e9175 |
|
•
•
•
•
•
|
Publication |
First Author: |
Shimizu N |
Year: |
2000 |
Journal: |
J Virol |
Title: |
A putative G protein-coupled receptor, RDC1, is a novel coreceptor for human and simian immunodeficiency viruses. |
Volume: |
74 |
Issue: |
2 |
Pages: |
619-26 |
|
•
•
•
•
•
|
Publication |
First Author: |
Rajagopal S |
Year: |
2010 |
Journal: |
Proc Natl Acad Sci U S A |
Title: |
Beta-arrestin- but not G protein-mediated signaling by the "decoy" receptor CXCR7. |
Volume: |
107 |
Issue: |
2 |
Pages: |
628-32 |
|
•
•
•
•
•
|
Publication |
First Author: |
Hattermann K |
Year: |
2010 |
Journal: |
Cancer Res |
Title: |
The chemokine receptor CXCR7 is highly expressed in human glioma cells and mediates antiapoptotic effects. |
Volume: |
70 |
Issue: |
8 |
Pages: |
3299-308 |
|
•
•
•
•
•
|
Publication |
First Author: |
Miao Z |
Year: |
2007 |
Journal: |
Proc Natl Acad Sci U S A |
Title: |
CXCR7 (RDC1) promotes breast and lung tumor growth in vivo and is expressed on tumor-associated vasculature. |
Volume: |
104 |
Issue: |
40 |
Pages: |
15735-40 |
|
•
•
•
•
•
|
Publication |
First Author: |
Zabel BA |
Year: |
2009 |
Journal: |
J Immunol |
Title: |
Elucidation of CXCR7-mediated signaling events and inhibition of CXCR4-mediated tumor cell transendothelial migration by CXCR7 ligands. |
Volume: |
183 |
Issue: |
5 |
Pages: |
3204-11 |
|
•
•
•
•
•
|
Protein Domain |
Type: |
Family |
Description: |
Just like classical chemokine receptors, atypical chemokine receptors (ACKRs) are seven-transmembrane-helix (7TM) receptors that bind chemokines []. However, they lack the canonical DRYLAIV motif necessary for GPCR coupling to G proteins and induction of classical signalling pathways. Instead, ACKRs internalise their chemokine ligands, which may subsequently affect chemokine availability. The ACKR family comprises five members: Duffy Antigen Receptor for Chemokines (DARC, ACKR1), D6 (ACKR2), CXCR7 (ACKR3), CCRL1 (ACKR4) and CCRL2 (ACKR5) [].Atypical chemokine receptor 3 (ACKR3), previously known as CXC chemokine receptor 7 (CXCR7), is regarded as a scavenger for CXCL12 and, to a lesser extent, for CXCL11 []. Unlike other CXC chemokine receptors, ACKR3 does not elicit classical chemokine receptor signalling via typical G protein-mediated pathways [], but instead induces beta-arrestin recruitment, leading to ligand internalisation and activation of MAPK signaling pathway [, ].ACKR3/CXCR7 has been identified on memory B cells and in mammals is found in bone, brain, heart and kidney [, ]. It has been shown to act as a novel coreceptor for several immunodeficiency virus strains, which infect brain-derived cells []. Studies in zebrafish have also revealed a critical role in vascular formation and angiogenesis during development []. ACKR3/CXCR7 is a functional receptor for CXCL12 in astrocytomas/glioblastomas and mediates resistance to drug-induced apoptosis []. It has been shown to promote growth of tumors formed from breast and lung cancer cells []. |
|
•
•
•
•
•
|
Publication |
First Author: |
Batdorf HM |
Year: |
2023 |
Journal: |
Am J Physiol Endocrinol Metab |
Title: |
NOD mice have distinct metabolic and immunologic profiles when compared with genetically similar MHC-matched ICR mice. |
Volume: |
325 |
Issue: |
4 |
Pages: |
E336-E345 |
|
•
•
•
•
•
|
Publication |
First Author: |
Nibbs RJ |
Year: |
2013 |
Journal: |
Nat Rev Immunol |
Title: |
Immune regulation by atypical chemokine receptors. |
Volume: |
13 |
Issue: |
11 |
Pages: |
815-29 |
|
•
•
•
•
•
|
Publication |
First Author: |
Bachelerie F |
Year: |
2014 |
Journal: |
Nat Immunol |
Title: |
New nomenclature for atypical chemokine receptors. |
Volume: |
15 |
Issue: |
3 |
Pages: |
207-8 |
|
•
•
•
•
•
|
Publication |
First Author: |
Weng Y |
Year: |
1998 |
Journal: |
J Biol Chem |
Title: |
Binding and functional properties of recombinant and endogenous CXCR3 chemokine receptors. |
Volume: |
273 |
Issue: |
29 |
Pages: |
18288-91 |
|
•
•
•
•
•
|
Publication |
First Author: |
Loetscher M |
Year: |
1996 |
Journal: |
J Exp Med |
Title: |
Chemokine receptor specific for IP10 and mig: structure, function, and expression in activated T-lymphocytes. |
Volume: |
184 |
Issue: |
3 |
Pages: |
963-9 |
|
•
•
•
•
•
|
Publication |
First Author: |
GarcÃa-López MA |
Year: |
2001 |
Journal: |
Lab Invest |
Title: |
CXCR3 chemokine receptor distribution in normal and inflamed tissues: expression on activated lymphocytes, endothelial cells, and dendritic cells. |
Volume: |
81 |
Issue: |
3 |
Pages: |
409-18 |
|
•
•
•
•
•
|
Publication |
First Author: |
Booth V |
Year: |
2002 |
Journal: |
Biochemistry |
Title: |
The CXCR3 binding chemokine IP-10/CXCL10: structure and receptor interactions. |
Volume: |
41 |
Issue: |
33 |
Pages: |
10418-25 |
|
•
•
•
•
•
|
Publication |
First Author: |
Smit MJ |
Year: |
2003 |
Journal: |
Blood |
Title: |
CXCR3-mediated chemotaxis of human T cells is regulated by a Gi- and phospholipase C-dependent pathway and not via activation of MEK/p44/p42 MAPK nor Akt/PI-3 kinase. |
Volume: |
102 |
Issue: |
6 |
Pages: |
1959-65 |
|
•
•
•
•
•
|
Publication |
First Author: |
Hancock WW |
Year: |
2000 |
Journal: |
J Exp Med |
Title: |
Requirement of the chemokine receptor CXCR3 for acute allograft rejection. |
Volume: |
192 |
Issue: |
10 |
Pages: |
1515-20 |
|
•
•
•
•
•
|
Publication |
First Author: |
Mach F |
Year: |
1999 |
Journal: |
J Clin Invest |
Title: |
Differential expression of three T lymphocyte-activating CXC chemokines by human atheroma-associated cells. |
Volume: |
104 |
Issue: |
8 |
Pages: |
1041-50 |
|
•
•
•
•
•
|
Publication |
First Author: |
Jiang D |
Year: |
2004 |
Journal: |
J Clin Invest |
Title: |
Regulation of pulmonary fibrosis by chemokine receptor CXCR3. |
Volume: |
114 |
Issue: |
2 |
Pages: |
291-9 |
|
•
•
•
•
•
|
Publication |
First Author: |
Frigerio S |
Year: |
2002 |
Journal: |
Nat Med |
Title: |
Beta cells are responsible for CXCR3-mediated T-cell infiltration in insulitis. |
Volume: |
8 |
Issue: |
12 |
Pages: |
1414-20 |
|
•
•
•
•
•
|
Publication |
First Author: |
Panzer U |
Year: |
2007 |
Journal: |
J Am Soc Nephrol |
Title: |
Chemokine receptor CXCR3 mediates T cell recruitment and tissue injury in nephrotoxic nephritis in mice. |
Volume: |
18 |
Issue: |
7 |
Pages: |
2071-84 |
|
•
•
•
•
•
|
Publication |
First Author: |
Qin S |
Year: |
1998 |
Journal: |
J Clin Invest |
Title: |
The chemokine receptors CXCR3 and CCR5 mark subsets of T cells associated with certain inflammatory reactions. |
Volume: |
101 |
Issue: |
4 |
Pages: |
746-54 |
|
•
•
•
•
•
|
Publication |
First Author: |
Curbishley SM |
Year: |
2005 |
Journal: |
Am J Pathol |
Title: |
CXCR 3 activation promotes lymphocyte transendothelial migration across human hepatic endothelium under fluid flow. |
Volume: |
167 |
Issue: |
3 |
Pages: |
887-99 |
|
•
•
•
•
•
|
Publication |
First Author: |
Loetscher P |
Year: |
2000 |
Journal: |
Adv Immunol |
Title: |
Chemokines and their receptors in lymphocyte traffic and HIV infection. |
Volume: |
74 |
|
Pages: |
127-80 |
|
•
•
•
•
•
|
Publication |
First Author: |
Zlotnik A |
Year: |
1999 |
Journal: |
Crit Rev Immunol |
Title: |
Recent advances in chemokines and chemokine receptors. |
Volume: |
19 |
Issue: |
1 |
Pages: |
1-47 |
|
•
•
•
•
•
|
Publication |
First Author: |
Yates CC |
Year: |
2007 |
Journal: |
Am J Pathol |
Title: |
Delayed and deficient dermal maturation in mice lacking the CXCR3 ELR-negative CXC chemokine receptor. |
Volume: |
171 |
Issue: |
2 |
Pages: |
484-95 |
|
•
•
•
•
•
|
Publication |
First Author: |
Xanthou G |
Year: |
2003 |
Journal: |
Eur J Immunol |
Title: |
CCR3 functional responses are regulated by both CXCR3 and its ligands CXCL9, CXCL10 and CXCL11. |
Volume: |
33 |
Issue: |
8 |
Pages: |
2241-50 |
|
•
•
•
•
•
|
Protein Domain |
Type: |
Family |
Description: |
Chemokines (chemotactic cytokines) are a family of chemoattractant molecules. They attract leukocytes to areas of inflammation and lesions, and play a key role in leukocyte activation. Originally defined as host defense proteins, chemokines are now known to play a much broader biological role []. They have a wide range of effects in many different cell types beyond the immune system, including, for example, various cells of the central nervous system [], and endothelial cells, where they may act as either angiogenic or angiostatic factors [].The chemokine family is divided into four classes based on the number and spacing of their conserved cysteines: 2 Cys residues may be adjacent (the CC family); separated by an intervening residue (the CXC family); have only one of the first two Cys residues (C chemokines); or contain both cysteines, separated by three intervening residues (CX3C chemokines).Chemokines exert their effects by binding to rhodopsin-like G protein-coupled receptors on the surface of cells. Following interaction with their specific chemokine ligands, chemokine receptors trigger a flux in intracellular calcium ions, which cause a cellular response, including the onset of chemotaxis. There are over fifty distinct chemokines and least 18 human chemokine receptors []. Although the receptors bind only a single class of chemokines, they often bind several members of the same class with high affinity. Chemokine receptors are preferentially expressed on important functional subsets of dendritic cells, monocytes and lymphocytes, including Langerhans cells and T helper cells [, ]. Chemokines and their receptors can also be subclassified into homeostatic leukocyte homing molecules (CXCR4, CXCR5, CCR7, CCR9) versus inflammatory/inducible molecules (CXCR1, CXCR2, CXCR3, CCR1-6, CX3CR1).The CXC chemokine receptors are a subfamily of chemokine receptors that specifically bind and respond to cytokines of the CXC chemokine family. There are currently seven known CXC chemokine receptors in mammals, CXCR1 through to CXCR7.This entry represents CXCR3, which is expressed in natural killer cells and activated T lymphocytes but not in resting T lymphocytes, B lymphocytes, monocytes or granulocytes [, ]. CXCR3 also appears to be constitutively expressed on endothelial cells of medium and large blood vessels []. CXCR3 is able to regulate leukocyte trafficking and binding to various chemokines inducing various cellular responses, most notably integrin activation, cytoskeletal changes and chemotactic migration [, , , ]. The main role of CXCR3 is the selective recruitment of effector T cells in both normal tissues and inflammation []and it is involved in a number of T cell-mediated inflammatory diseases, such as autoimmune diseases, delayed-type hypersensitivity responses, certain viral diseases and acute transplant rejection []. It has been implicated in atherosclerosis [], pulmonary fibrosis [], type 1 diabetes []and nephrotoxic nephritis [], and has been implicated in wound healing [].CXCR3 is the receptor for CXCL9 (Mig), CXCL10 (IP10) and CXCL11 (I-TAC), [, , , ], which are upregulated in response to interferon-gamma and are potent chemoattractants for activated T cells [, ]. All three chemokines elicit an increase in intracellular Ca2+ levels and activate phosphoinositide 3-kinase and mitogen-activated protein kinase (MAPK) []. CXCR3 is also capable of binding a number of CC chemokines with moderate affinity, including CCL11 (eotaxin), CCL13, CCL20, CCL7, CCL5 []. However, it has been reported that CCL11, despite binding with high affinity, may be neither an agonist or an antagonist of the CXCR3 receptor, but sequesters available CCL11 resulting in a lowered response at other receptors []. |
|
•
•
•
•
•
|
Protein |
Organism: |
Mus musculus/domesticus |
Length: |
362
 |
Fragment?: |
false |
|
•
•
•
•
•
|
Publication |
First Author: |
Murphy PM |
Year: |
2000 |
Journal: |
Pharmacol Rev |
Title: |
International union of pharmacology. XXII. Nomenclature for chemokine receptors. |
Volume: |
52 |
Issue: |
1 |
Pages: |
145-76 |
|
•
•
•
•
•
|
Protein |
Organism: |
Mus musculus/domesticus |
Length: |
367
 |
Fragment?: |
false |
|
•
•
•
•
•
|
Publication |
First Author: |
Ma Q |
Year: |
1998 |
Journal: |
Proc Natl Acad Sci U S A |
Title: |
Impaired B-lymphopoiesis, myelopoiesis, and derailed cerebellar neuron migration in CXCR4- and SDF-1-deficient mice. |
Volume: |
95 |
Issue: |
16 |
Pages: |
9448-53 |
|
•
•
•
•
•
|
Publication |
First Author: |
Horuk R |
Year: |
2001 |
Journal: |
Cytokine Growth Factor Rev |
Title: |
Chemokine receptors. |
Volume: |
12 |
Issue: |
4 |
Pages: |
313-35 |
|
•
•
•
•
•
|
Publication |
First Author: |
Charbonnier AS |
Year: |
1999 |
Journal: |
J Exp Med |
Title: |
Macrophage inflammatory protein 3alpha is involved in the constitutive trafficking of epidermal langerhans cells. |
Volume: |
190 |
Issue: |
12 |
Pages: |
1755-68 |
|
•
•
•
•
•
|
Publication |
First Author: |
Sallusto F |
Year: |
1998 |
Journal: |
J Exp Med |
Title: |
Flexible programs of chemokine receptor expression on human polarized T helper 1 and 2 lymphocytes. |
Volume: |
187 |
Issue: |
6 |
Pages: |
875-83 |
|
•
•
•
•
•
|
Publication |
First Author: |
Strieter RM |
Year: |
1995 |
Journal: |
J Biol Chem |
Title: |
The functional role of the ELR motif in CXC chemokine-mediated angiogenesis. |
Volume: |
270 |
Issue: |
45 |
Pages: |
27348-57 |
|
•
•
•
•
•
|
Publication |
First Author: |
Zlotnik A |
Year: |
2000 |
Journal: |
Immunity |
Title: |
Chemokines: a new classification system and their role in immunity. |
Volume: |
12 |
Issue: |
2 |
Pages: |
121-7 |
|
•
•
•
•
•
|
Publication |
First Author: |
The Gene Expression Nervous System Atlas (GENSAT) Project, The Rockefeller University (New York, NY) |
Year: |
2005 |
Journal: |
Database Download |
Title: |
MGI download of GENSAT transgene data |
|
|
|
|
•
•
•
•
•
|